Award Categories include Device Design, Innovation and Leadership which recognize achievements in manufacturing, technology, materials and team performance.
Companies spoke about the need for navigation, robotics and AI at NASS 2024.
Outpatient surgery is the vanguard of modern healthcare and the future of surgical and medical innovation, says an ASC investor.
The addition of these technologies will allow Demetra to expand its portfolio of infection management solutions.
The next-generation, radiation-free optical navigation complements the Highridge portfolio of enabling technologies.
VergenixSTR for the treatment of tendinopathy is now available in Poland.
This collaboration will expand access of Elute’s BonVie+ bone graft substitute to physicians and patients at U.S. VA and DoD medical facilities worldwide.
New systems seek to simplify use of the technology by tapping into equipment in the O.R., offering ASC-friendly sizes and including AI applications.
Aurelio Sahagun will succeed Darin Johnson as new company CEO upon successful closing of the sale of the company.
In conjunction Demetra launched Demetra Spine, a new global business unit, established to support spinal surgery with forward-thinking, value-based solutions.
Stryker’s spinal implants business in Australia and New Zealand has fully transitioned to VB Spine, and LifeHealthcare continues as exclusive distributor.
Companies seek to develop next-generation, minimally invasive treatments that fundamentally change the treatment paradigm in knee osteoarthritis.
Amplitude Surgical develops and markets products for orthopedic surgery, covering the main pathologies affecting the hip and knee.
BioPoly has made a string of announcements related to new product introductions, patents, studies and an Innovative Technology contract.
Keith Pfeil, formerly Executive Vice President, Chief Operating Officer and Chief Financial Officer, has been appointed President and Chief Executive Officer.
Zimmer Biomet is betting that a portfolio of technologies that support surgeon preferences will help it gain ground in robotics and defend its joint replacement position.
The partnership provides Medartis access to a hand portfolio while enhancing the company’s technological expertise in joint replacement.
Substantially all assets of the company are for sale, including the NUVIS wireless arthroscopy platform.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.